Hepatitis C virus resistance to the new direct-acting antivirals

I Esposito, J Trinks, V Soriano - Expert opinion on drug metabolism …, 2016 - Taylor & Francis
Introduction: The treatment of hepatitis C virus (HCV) infection has dramatically improved in
recent years with the widespread use of interferon-free combination regimens. Despite the …

[HTML][HTML] Influence of ethnicity on the distribution of genetic polymorphisms associated with risk of chronic liver disease in South American populations

AC Pontoriero, J Trinks, ML Hulaniuk, M Caputo… - BMC genetics, 2015 - Springer
Background The global burden of chronic liver disease is rising. Besides environmental,
behavioral, viral and metabolic factors, genetic polymorphisms in patatin-like phospholipase-3 (…

[HTML][HTML] A two-time point analysis of gut microbiota in the general population of buenos aires and its variation due to preventive and compulsory social isolation during …

…, S Quesada, I Llovet, G Iraola, J Trinks… - Frontiers in …, 2022 - frontiersin.org
The COVID-19 pandemic poses a great challenge to global public health. The extraordinary
daily use of household disinfectants and cleaning products, social distancing and the loss of …

Detection of hepatitis B virus (HBV) genotype E carried—even in the presence of high titers of anti-HBs antibodies—by an Argentinean patient of African descent who …

…, V Ruiz, ML Minassian, C Rivero, J Trinks… - Journal of clinical …, 2006 - Am Soc Microbiol
Genotype E hepatitis B virus (HBV) was detected in two Argentine sisters exhibiting an African
mitochondrial lineage. One of them (who had been vaccinated against HBV) exhibited anti…

Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype

…, ML Marro, A Penas-Steinhardt, J Trinks - Metabolomics, 2021 - Springer
Introduction Non-invasive biomarkers are needed for metabolic dysfunction-associated fatty
liver disease (MAFLD), especially for patients at risk of disease progression in high-…

Role of HLA‐DP and HLA‐DQ on the clearance of hepatitis B virus and the risk of chronic infection in a multiethnic population

J Trinks, N Nishida, ML Hulaniuk, M Caputo… - Liver …, 2017 - Wiley Online Library
… and the risk of chronic infection in a multiethnic population - Trinks - 2017 - Liver International
- Wiley Online Library … Julieta Trinks and Nao Nishida contributed equally to this study. …

Naturally occurring hepatitis B virus (HBV) variants with primary resistance to antiviral therapy and S-mutants with potential primary resistance to adefovir in Argentina

…, ML Minassian, AI Castillo, EA Gentile, J Trinks… - Antiviral research, 2010 - Elsevier
Hepatitis B virus (HBV) variants may either emerge in patients with chronic hepatitis B (CHB)
as a result of positive selection pressure exerted by their own immune response, or during …

[HTML][HTML] Omics-based biomarkers as useful tools in metabolic dysfunction-associated steatotic liver disease clinical practice: How far are we?

J Trinks, MF Mascardi, A Gadano… - World Journal of …, 2024 - ncbi.nlm.nih.gov
Unmet needs exist in metabolic dysfunction-associated steatotic liver disease (MASLD) risk
stratification. Our ability to identify patients with MASLD with advanced fibrosis and at higher …

[HTML][HTML] Unexpected high seroprevalence of hepatitis E virus in patients with alcohol-related cirrhosis

AC Fantilli, J Trinks, S Marciano, F Zárate… - PLoS …, 2019 - journals.plos.org
Introduction Little is known about hepatitis E virus (HEV) infection in patients with cirrhosis.
The aim of the present study was to describe the frequency of HEV infection and associated …

[HTML][HTML] Prevalence and factors related to natural resistance-associated substitutions to direct-acting antivirals in patients with genotype 1 hepatitis C virus infection

…, O Galdame, A Franco, A Gadano, D Flichman, J Trinks - Viruses, 2018 - mdpi.com
This study aimed to assess the prevalence of natural resistance-associated substitutions (RASs)
to NS3, NS5A and NS5B inhibitors in 86 genotype 1 Hepatitis C Virus (HCV)-infected …